Abstract
Summary
The global market for Vaccine Shippers was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Vaccine Shippers, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Vaccine Shippers by region & country, by Type, and by Application.
The Vaccine Shippers market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Shippers.
Market Segmentation
By Company
Softbox Systems
Envirotainer
Intelsius
Amerisource Bergen
Marken
Kuehne+Nagel
Pelican Biothermal
DHL International gmbh
Geodis
Sonoco Thermosafe
Cold chain Technologies
Sofrigam
Tempak
Segment by Type:
< -2°C
-2 to -8°C
15-25°C
> 25°C
Segment by Application
Single-use Vaccine Shippers
Reusable Vaccine Shippers
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Vaccine Shippers manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Vaccine Shippers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Vaccine Shippers in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Vaccine Shippers, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Vaccine Shippers by region & country, by Type, and by Application.
The Vaccine Shippers market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Shippers.
Market Segmentation
By Company
Softbox Systems
Envirotainer
Intelsius
Amerisource Bergen
Marken
Kuehne+Nagel
Pelican Biothermal
DHL International gmbh
Geodis
Sonoco Thermosafe
Cold chain Technologies
Sofrigam
Tempak
Segment by Type:
< -2°C
-2 to -8°C
15-25°C
> 25°C
Segment by Application
Single-use Vaccine Shippers
Reusable Vaccine Shippers
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Vaccine Shippers manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Vaccine Shippers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Vaccine Shippers in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Vaccine Shippers Product Introduction
1.2 Global Vaccine Shippers Market Size Forecast
1.3 Vaccine Shippers Market Trends & Drivers
1.3.1 Vaccine Shippers Industry Trends
1.3.2 Vaccine Shippers Market Drivers & Opportunity
1.3.3 Vaccine Shippers Market Challenges
1.3.4 Vaccine Shippers Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Vaccine Shippers Players Revenue Ranking (2023)
2.2 Global Vaccine Shippers Revenue by Company (2019-2024)
2.3 Key Companies Vaccine Shippers Manufacturing Base Distribution and Headquarters
2.4 Key Companies Vaccine Shippers Product Offered
2.5 Key Companies Time to Begin Mass Production of Vaccine Shippers
2.6 Vaccine Shippers Market Competitive Analysis
2.6.1 Vaccine Shippers Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Vaccine Shippers Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Shippers as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 < -2°C
3.1.2 -2 to -8°C
3.1.3 15-25°C
3.1.4 > 25°C
3.2 Global Vaccine Shippers Sales Value by Type
3.2.1 Global Vaccine Shippers Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Vaccine Shippers Sales Value, by Type (2019-2030)
3.2.3 Global Vaccine Shippers Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Single-use Vaccine Shippers
4.1.2 Reusable Vaccine Shippers
4.2 Global Vaccine Shippers Sales Value by Application
4.2.1 Global Vaccine Shippers Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Vaccine Shippers Sales Value, by Application (2019-2030)
4.2.3 Global Vaccine Shippers Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Vaccine Shippers Sales Value by Region
5.1.1 Global Vaccine Shippers Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Vaccine Shippers Sales Value by Region (2019-2024)
5.1.3 Global Vaccine Shippers Sales Value by Region (2025-2030)
5.1.4 Global Vaccine Shippers Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Vaccine Shippers Sales Value, 2019-2030
5.2.2 North America Vaccine Shippers Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Vaccine Shippers Sales Value, 2019-2030
5.3.2 Europe Vaccine Shippers Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Vaccine Shippers Sales Value, 2019-2030
5.4.2 Asia Pacific Vaccine Shippers Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Vaccine Shippers Sales Value, 2019-2030
5.5.2 South America Vaccine Shippers Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Vaccine Shippers Sales Value, 2019-2030
5.6.2 Middle East & Africa Vaccine Shippers Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Vaccine Shippers Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Vaccine Shippers Sales Value
6.3 United States
6.3.1 United States Vaccine Shippers Sales Value, 2019-2030
6.3.2 United States Vaccine Shippers Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Vaccine Shippers Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Vaccine Shippers Sales Value, 2019-2030
6.4.2 Europe Vaccine Shippers Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Vaccine Shippers Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Vaccine Shippers Sales Value, 2019-2030
6.5.2 China Vaccine Shippers Sales Value by Type (%), 2023 VS 2030
6.5.3 China Vaccine Shippers Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Vaccine Shippers Sales Value, 2019-2030
6.6.2 Japan Vaccine Shippers Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Vaccine Shippers Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Vaccine Shippers Sales Value, 2019-2030
6.7.2 South Korea Vaccine Shippers Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Vaccine Shippers Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Vaccine Shippers Sales Value, 2019-2030
6.8.2 Southeast Asia Vaccine Shippers Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Vaccine Shippers Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Vaccine Shippers Sales Value, 2019-2030
6.9.2 India Vaccine Shippers Sales Value by Type (%), 2023 VS 2030
6.9.3 India Vaccine Shippers Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Softbox Systems
7.1.1 Softbox Systems Profile
7.1.2 Softbox Systems Main Business
7.1.3 Softbox Systems Vaccine Shippers Products, Services and Solutions
7.1.4 Softbox Systems Vaccine Shippers Revenue (US$ Million) & (2019-2024)
7.1.5 Softbox Systems Recent Developments
7.2 Envirotainer
7.2.1 Envirotainer Profile
7.2.2 Envirotainer Main Business
7.2.3 Envirotainer Vaccine Shippers Products, Services and Solutions
7.2.4 Envirotainer Vaccine Shippers Revenue (US$ Million) & (2019-2024)
7.2.5 Envirotainer Recent Developments
7.3 Intelsius
7.3.1 Intelsius Profile
7.3.2 Intelsius Main Business
7.3.3 Intelsius Vaccine Shippers Products, Services and Solutions
7.3.4 Intelsius Vaccine Shippers Revenue (US$ Million) & (2019-2024)
7.3.5 Amerisource Bergen Recent Developments
7.4 Amerisource Bergen
7.4.1 Amerisource Bergen Profile
7.4.2 Amerisource Bergen Main Business
7.4.3 Amerisource Bergen Vaccine Shippers Products, Services and Solutions
7.4.4 Amerisource Bergen Vaccine Shippers Revenue (US$ Million) & (2019-2024)
7.4.5 Amerisource Bergen Recent Developments
7.5 Marken
7.5.1 Marken Profile
7.5.2 Marken Main Business
7.5.3 Marken Vaccine Shippers Products, Services and Solutions
7.5.4 Marken Vaccine Shippers Revenue (US$ Million) & (2019-2024)
7.5.5 Marken Recent Developments
7.6 Kuehne+Nagel
7.6.1 Kuehne+Nagel Profile
7.6.2 Kuehne+Nagel Main Business
7.6.3 Kuehne+Nagel Vaccine Shippers Products, Services and Solutions
7.6.4 Kuehne+Nagel Vaccine Shippers Revenue (US$ Million) & (2019-2024)
7.6.5 Kuehne+Nagel Recent Developments
7.7 Pelican Biothermal
7.7.1 Pelican Biothermal Profile
7.7.2 Pelican Biothermal Main Business
7.7.3 Pelican Biothermal Vaccine Shippers Products, Services and Solutions
7.7.4 Pelican Biothermal Vaccine Shippers Revenue (US$ Million) & (2019-2024)
7.7.5 Pelican Biothermal Recent Developments
7.8 DHL International gmbh
7.8.1 DHL International gmbh Profile
7.8.2 DHL International gmbh Main Business
7.8.3 DHL International gmbh Vaccine Shippers Products, Services and Solutions
7.8.4 DHL International gmbh Vaccine Shippers Revenue (US$ Million) & (2019-2024)
7.8.5 DHL International gmbh Recent Developments
7.9 Geodis
7.9.1 Geodis Profile
7.9.2 Geodis Main Business
7.9.3 Geodis Vaccine Shippers Products, Services and Solutions
7.9.4 Geodis Vaccine Shippers Revenue (US$ Million) & (2019-2024)
7.9.5 Geodis Recent Developments
7.10 Sonoco Thermosafe
7.10.1 Sonoco Thermosafe Profile
7.10.2 Sonoco Thermosafe Main Business
7.10.3 Sonoco Thermosafe Vaccine Shippers Products, Services and Solutions
7.10.4 Sonoco Thermosafe Vaccine Shippers Revenue (US$ Million) & (2019-2024)
7.10.5 Sonoco Thermosafe Recent Developments
7.11 Cold chain Technologies
7.11.1 Cold chain Technologies Profile
7.11.2 Cold chain Technologies Main Business
7.11.3 Cold chain Technologies Vaccine Shippers Products, Services and Solutions
7.11.4 Cold chain Technologies Vaccine Shippers Revenue (US$ Million) & (2019-2024)
7.11.5 Cold chain Technologies Recent Developments
7.12 Sofrigam
7.12.1 Sofrigam Profile
7.12.2 Sofrigam Main Business
7.12.3 Sofrigam Vaccine Shippers Products, Services and Solutions
7.12.4 Sofrigam Vaccine Shippers Revenue (US$ Million) & (2019-2024)
7.12.5 Sofrigam Recent Developments
7.13 Tempak
7.13.1 Tempak Profile
7.13.2 Tempak Main Business
7.13.3 Tempak Vaccine Shippers Products, Services and Solutions
7.13.4 Tempak Vaccine Shippers Revenue (US$ Million) & (2019-2024)
7.13.5 Tempak Recent Developments
8 Industry Chain Analysis
8.1 Vaccine Shippers Industrial Chain
8.2 Vaccine Shippers Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Vaccine Shippers Sales Model
8.5.2 Sales Channel
8.5.3 Vaccine Shippers Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer